Bolt Projects Holdings, Inc. (BSLK)

The past six months have seen several significant events impacting BSLK's stock price. The company reported full-year 2024 revenues of $1.4 million, exceeding initial projections, and projected revenues of $4.5 million for 2025 and $9.0 million for 2026. Q1 2025 revenue increased nine-fold year-over-year to $0.2 million with breakeven gross margins, adding two new customers and expanding its patent portfolio. Q2 2025 revenue surged 23x year-over-year to $1.3 million, achieving positive gross margins ahead of schedule and securing its first partnership with a major beauty conglomerate, leading to a stock price surge. Q3 2025 reported $0.37 million in revenue (up 7,300% year-over-year) and a 16% gross margin, reiterating full-year revenue guidance. Preliminary fiscal 2025 results expected revenue around $4.5 million, and raised fiscal 2026 revenue guidance to $11.0 million. The company completed a 20-to-1 reverse stock split in April 2025. The company entered a non-binding term sheet for up to $20 million in financing from Ascent Partners in Q2 2025. Recent financings in Q3 2025 included an August private placement, conversion of payables, and drawn on an equity line. A proposed financing of up to $30.0 million in convertible notes and warrants was ongoing in December 2025. Nasdaq granted a compliance extension. BSLK's share price has been volatile, with a significant decline in 2025 and a drop leading up to January 2026.

While there is information regarding the seasonality of BSLK's stock returns, the company's financial reports and news indicate a "surging demand" for its Vegan Silk Technology Platform and growing interest from new and existing customers in the beauty and personal care industry. This suggests a growing, rather than highly seasonal, demand for its biomaterials as the industry shifts towards sustainable ingredients.

Bolt Projects Holdings, Inc. (BSLK) is a biomaterials company based in San Francisco, California, operating in the Materials sector, specifically the Specialty Chemicals and Commodity Chemicals industries. The company focuses on developing and producing biomaterials for the beauty and personal care industry, with primary products being b-silk and xl-silk, part of its Vegan Silk Technology Platform. These are biodegradable, film-forming, versatile, and functional ingredients designed as vegan and biodegradable replacements for silicone elastomers. The company's intellectual property includes 68 granted patents and 166 pending patent applications.

Bolt Projects Holdings, Inc. is based in San Francisco, California, and develops and produces biomaterials products in the United States.

Bolt Projects Holdings has cultivated a positive brand reputation within its niche, driven by the increasing demand for its Vegan Silk Technology Platform. The company has secured strategic partnerships with notable entities in the beauty industry, including Haus Labs and Goddess Maintenance Company. A new partnership with one of the seven major beauty conglomerates was also highlighted, with a global skincare brand planning to launch its first product featuring Vegan Silk in 2026. These collaborations and the surging demand for its eco-friendly and sustainable biomaterials indicate a strong and growing reputation for innovation and sustainability in the beauty and personal care market.

Bolt Projects Holdings, Inc.'s ownership structure comprises institutional, retail, and individual investors. Approximately 8.04% to 9.08% of the company's stock is held by institutional investors, 4.10% to 10.60% by insiders, and a significant portion, around 87.02%, by public companies and individual investors (retail investors). Major institutional shareholders include Temasek Holdings, Baillie Gifford & Co, DRW Securities, LLC, Nan Fung Group Holdings Ltd, Vanguard Group Inc, Schonfeld Strategic Advisors LLC, and Bank Of Montreal. Randy Befumo owns the most shares among individual investors, and insider buying activity has been observed.